Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design

G Bahr, LJ Gonzalez, AJ Vila - Chemical reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …

β-lactam/β-lactamase inhibitor combinations: an update

KHME Tehrani, NI Martin - Medchemcomm, 2018 - pubs.rsc.org
Antibiotic resistance caused by β-lactamase production continues to present a growing
challenge to the efficacy of β-lactams and their role as the most important class of clinically …

Metallo-β-lactamase inhibitors inspired on snapshots from the catalytic mechanism

AR Palacios, MA Rossi, GS Mahler, AJ Vila - Biomolecules, 2020 - mdpi.com
β-Lactam antibiotics are the most widely prescribed antibacterial drugs due to their low
toxicity and broad spectrum. Their action is counteracted by different resistance mechanisms …

Recent research and development of NDM-1 inhibitors

T Wang, K Xu, L Zhao, R Tong, L Xiong, J Shi - European journal of …, 2021 - Elsevier
Abstract Bacteria carrying New Delhi metallo-β-lactamase-1 (New Delhi metallo-β-
lactamase, NDM-1) resistance gene is a new type of “superbug”, which can hydrolyze …

Optimization of 1, 2, 4-triazole-3-thiones toward broad-spectrum metallo-β-lactamase inhibitors showing potent synergistic activity on VIM-and NDM-1-producing …

A Legru, F Verdirosa, Y Vo-Hoang… - Journal of Medicinal …, 2022 - ACS Publications
Metallo-β-lactamases (MBLs) contribute to the resistance of Gram-negative bacteria to
carbapenems, last-resort antibiotics at hospital, and MBL inhibitors are urgently needed to …

Diversity and proliferation of metallo-β-lactamases: a clarion call for clinically effective metallo-β-lactamase inhibitors

AM Somboro, J Osei Sekyere, DG Amoako… - Applied and …, 2018 - Am Soc Microbiol
The worldwide proliferation of life-threatening metallo-β-lactamase (MBL)-producing Gram-
negative bacteria is a serious concern to public health. MBLs are compromising the …

Principles and current strategies targeting metallo‐β‐lactamase mediated antibacterial resistance

YH Yan, G Li, GB Li - Medicinal Research Reviews, 2020 - Wiley Online Library
Resistance to β‐lactam antibacterials is commonly associated with the production of the
serine β‐lactamases (SBLs) and/or metallo‐β‐lactamases (MBLs). Although clinically useful …

Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1)

KCN Venkata, M Ellebrecht, SK Tripathi - European journal of medicinal …, 2021 - Elsevier
Antimicrobial stewardship is imperative when treating bacterial infections because the
misuse and overuse of antibiotics have caused pathogens to develop life-threatening …

Drug development concerning metallo-β-lactamases in gram-negative bacteria

X Li, J Zhao, B Zhang, X Duan, J Jiao, W Wu… - Frontiers in …, 2022 - frontiersin.org
β-Lactams have been a clinical focus since their emergence and indeed act as a powerful
tool to combat severe bacterial infections, but their effectiveness is threatened by drug …

A 2018–2019 patent review of metallo beta-lactamase inhibitors

N Reddy, M Shungube, PI Arvidsson… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Antibiotic resistance caused by beta-lactamase expressing bacteria poses a
concern given its global dissemination and proliferation. The emergence of the metallo beta …